These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30121162)

  • 1. Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease.
    Rizzone MG; Martone T; Balestrino R; Lopiano L
    Parkinsonism Relat Disord; 2019 Jul; 64():8-19. PubMed ID: 30121162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep brain stimulation for monogenic Parkinson's disease: a systematic review.
    Kuusimäki T; Korpela J; Pekkonen E; Martikainen MH; Antonini A; Kaasinen V
    J Neurol; 2020 Apr; 267(4):883-897. PubMed ID: 30659355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson-related genetics in patients treated with deep brain stimulation.
    Johansen KK; Jørgensen JV; White LR; Farrer MJ; Aasly JO
    Acta Neurol Scand; 2011 Mar; 123(3):201-6. PubMed ID: 20545633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor and Non-motor Outcomes of Deep Brain Stimulation across the Genetic Panorama of Parkinson's Disease: A Multi-Scale Meta-Analysis.
    Asimakidou E; Xiromerisiou G; Sidiropoulos C
    Mov Disord Clin Pract; 2024 May; 11(5):465-477. PubMed ID: 38318989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
    Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
    JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort.
    Avenali M; Zangaglia R; Cuconato G; Palmieri I; Albanese A; Artusi CA; Bozzali M; Calandra-Buonaura G; Cavallieri F; Cilia R; Cocco A; Cogiamanian F; Colucci F; Cortelli P; Di Fonzo A; Eleopra R; Giannini G; Imarisio A; Imbalzano G; Ledda C; Lopiano L; Malaguti MC; Mameli F; Minardi R; Mitrotti P; Monfrini E; Spagnolo F; Tassorelli C; Valentino F; Valzania F; Pacchetti C; Valente EM;
    J Neurol Neurosurg Psychiatry; 2024 Mar; 95(4):309-315. PubMed ID: 37879897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation.
    Angeli A; Mencacci NE; Duran R; Aviles-Olmos I; Kefalopoulou Z; Candelario J; Rusbridge S; Foley J; Pradhan P; Jahanshahi M; Zrinzo L; Hariz M; Wood NW; Hardy J; Limousin P; Foltynie T
    Mov Disord; 2013 Sep; 28(10):1370-5. PubMed ID: 23818421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.
    Pal GD; Hall D; Ouyang B; Phelps J; Alcalay R; Pauciulo MW; Nichols WC; Clark L; Mejia-Santana H; Blasucci L; Goetz CG; Comella C; Colcher A; Gan-Or Z; Rouleau GA; Marder K;
    Mov Disord Clin Pract; 2016; 3(5):465-471. PubMed ID: 27709117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.
    Hanna JA; Scullen T; Kahn L; Mathkour M; Gouveia EE; Garces J; Evans LM; Lea G; Houghton DJ; Biro E; Bui CJ; Sulaiman OA; Smith RD
    J Neurosurg; 2018 Sep; 131(3):807-812. PubMed ID: 30265192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers.
    Sayad M; Zouambia M; Chaouch M; Ferrat F; Nebbal M; Bendini M; Lesage S; Brice A; Brahim Errahmani M; Asselah B
    BMC Neurosci; 2016 Feb; 17():6. PubMed ID: 26831335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation.
    Blomstedt P; Stenmark Persson R; Hariz GM; Linder J; Fredricks A; Häggström B; Philipsson J; Forsgren L; Hariz M
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):710-716. PubMed ID: 29386253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin mutation and deep brain stimulation outcome.
    Kim HJ; Yun JY; Kim YE; Lee JY; Kim HJ; Kim JY; Park SS; Paek SH; Jeon BS
    J Clin Neurosci; 2014 Jan; 21(1):107-10. PubMed ID: 24060625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation for Parkinson's disease: patient selection and motor outcomes.
    Chang VC; Chou KL
    Med Health R I; 2006 Apr; 89(4):142-4. PubMed ID: 16676911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.